A previous study has reported that S-adenosylhomocysteine (SAH) can trigger the activation of NF-κB pathway to induce endothelial dysfunction and activation, by partially inhibiting the enzymatic activity of EZH2 [24]. This evidence concerns the gene EZH2 and endothelial dysfunction.